• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢衰老患者在半自然周期中的体外受精与胚胎移植

In vitro fertilization and embryo transfer in seminatural cycles for patients with ovarian aging.

作者信息

Castelo Branco Altina, Achour-Frydman Nelly, Kadoch Jacques, Fanchin Renato, Tachdjian Gerard, Frydman René

机构信息

Department of Obstetrics and Gynecology and Reproductive Medicine, Hôpital Antoine Béclère, Clamart, France.

出版信息

Fertil Steril. 2005 Oct;84(4):875-80. doi: 10.1016/j.fertnstert.2005.03.067.

DOI:10.1016/j.fertnstert.2005.03.067
PMID:16213838
Abstract

OBJECTIVE

To investigate whether seminatural cycle is a reasonable management for ovarian aging patients.

DESIGN

Prospective study.

SETTING

ART Unit, Clamart, France.

PATIENT(S): Seventy-five women, 158 cycles.

INTERVENTION(S): Infertile women who presented with ovarian aging (defined as low ovarian reserve and characterized by cycle day 3 high FSH, high E2, and/or low inhibin B and/or previous cycle cancellations due to poor ovarian response to COH) were studied. Patients were offered up to three cycles. Treatment was scheduled as follows. From cycle day 8 onward the selection of the dominant follicle was monitored by ultrasound and hormonal measurements. When the dominant follicle appeared, patients received GnRH antagonist and, thereafter, hMG to support further follicular development.

MAIN OUTCOME MEASURE(S): Implantation rate and clinical pregnancy.

RESULT(S): Twenty-eight of 158 cycles were cancelled (17.7%). Oocyte pickups were performed in 119 (75.3%) cycles, 91 (57.6%) mature oocytes were retrieved, and 67 (42.4%) embryos transferred. Nineteen clinical pregnancies were obtained; the cumulative pregnancy rate per patient, after 3 cycles, was 35.2%.

CONCLUSION(S): Use of a seminatural cycle is a reasonable management for patients with ovarian aging who have ovulatory menstrual cycles. It achieves a high implantation rate (28.3%).

摘要

目的

探讨半自然周期对于卵巢衰老患者是否是一种合理的治疗方案。

设计

前瞻性研究。

地点

法国克拉马尔的辅助生殖科。

患者

75名女性,共158个周期。

干预措施

研究对象为患有卵巢衰老的不孕女性(定义为卵巢储备功能低下,表现为月经周期第3天FSH水平高、E2水平高和/或抑制素B水平低,和/或既往因对控制性卵巢刺激反应差而取消周期)。患者最多可接受三个周期的治疗。治疗安排如下。从月经周期第8天起,通过超声和激素测定监测优势卵泡的选择。当优势卵泡出现时,患者接受GnRH拮抗剂,此后接受hMG以支持卵泡进一步发育。

主要观察指标

种植率和临床妊娠率。

结果

158个周期中有28个(17.7%)被取消。119个(75.3%)周期进行了取卵,获得91个(57.6%)成熟卵子,移植67个(42.4%)胚胎。获得19例临床妊娠;每位患者在3个周期后的累积妊娠率为35.2%。

结论

对于有排卵性月经周期的卵巢衰老患者,采用半自然周期是一种合理的治疗方案。其种植率较高(28.3%)。

相似文献

1
In vitro fertilization and embryo transfer in seminatural cycles for patients with ovarian aging.卵巢衰老患者在半自然周期中的体外受精与胚胎移植
Fertil Steril. 2005 Oct;84(4):875-80. doi: 10.1016/j.fertnstert.2005.03.067.
2
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.抗苗勒管激素:卵泡早期、排卵期及黄体中期水平与卵胞浆内单精子注射患者卵巢反应及周期结局的相关性
Fertil Steril. 2008 Jun;89(6):1670-6. doi: 10.1016/j.fertnstert.2007.05.040. Epub 2007 Jul 20.
3
Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.反应不良女性的卵巢反应及妊娠结局:一项关于补充黄体生成素对体外受精周期影响的随机对照试验
Fertil Steril. 2008 Mar;89(3):546-53. doi: 10.1016/j.fertnstert.2007.03.088. Epub 2007 May 29.
4
Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.卵泡晚期每日低剂量人绒毛膜促性腺激素刺激卵巢用于体外受精:一项前瞻性随机试验。
Fertil Steril. 2006 Oct;86(4):830-8. doi: 10.1016/j.fertnstert.2006.02.110. Epub 2006 Sep 11.
5
A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.一项关于在启动促性腺激素释放激素拮抗剂后增加重组促卵泡激素用于体外受精-胚胎移植的随机对照试验。
Fertil Steril. 2006 Jul;86(1):58-63. doi: 10.1016/j.fertnstert.2005.12.040. Epub 2006 Jun 6.
6
Clinical use of colony-stimulating factor-1 in ovulation induction for poor responders.集落刺激因子-1在低反应者促排卵中的临床应用。
Fertil Steril. 2008 Dec;90(6):2287-90. doi: 10.1016/j.fertnstert.2007.10.043. Epub 2008 Aug 20.
7
Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.重组人促卵泡生成素卵巢反应降低的女性体外受精周期中卵泡内雌二醇水平降低。
Fertil Steril. 2005 May;83(5):1377-83. doi: 10.1016/j.fertnstert.2004.11.041.
8
Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.在选择阶段进行卵泡抽吸可预防接受体外受精的多囊卵巢综合征患者发生严重的卵巢过度刺激。
Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):79-84. doi: 10.1016/j.ejogrb.2005.01.023.
9
Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.高纯度人绝经期促性腺激素与重组促卵泡激素在首次体外受精-卵胞浆内单精子注射患者中的有效性比较
Fertil Steril. 2008 Jun;89(6):1685-93. doi: 10.1016/j.fertnstert.2007.05.039. Epub 2007 Aug 6.
10
[In vitro maturation and fertilization of unstimulated immature oocyte for the treatment of infertile women].未刺激的未成熟卵母细胞体外成熟与受精用于治疗不孕女性
Zhonghua Fu Chan Ke Za Zhi. 2006 Mar;41(3):173-6.

引用本文的文献

1
Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study.从少数改良自然周期中收集卵子以提高 IVF 结果:一项初步研究。
J Assist Reprod Genet. 2013 Nov;30(11):1465-70. doi: 10.1007/s10815-013-0103-1.
2
Day 3 embryo transfer may have better pregnancy outcomes in younger than 35-year-old patients with poor ovarian response.对于卵巢反应不良的 35 岁以下年轻患者,第 3 天胚胎移植可能会获得更好的妊娠结局。
J Assist Reprod Genet. 2012 Oct;29(10):1077-81. doi: 10.1007/s10815-012-9830-y. Epub 2012 Jul 20.